Global Intravenous Solutions (Colloids) Sales Market Report 2022

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Market Analysis and Insights: Global Intravenous Solutions (Colloids) Market
Due to the COVID-19 pandemic, the global Intravenous Solutions (Colloids) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Intravenous Solutions (Colloids) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
Global Intravenous Solutions (Colloids) Scope and Market Size
The global Intravenous Solutions (Colloids) market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Intravenous Solutions (Colloids) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospital and Clinics
Ambulatory
Home Care
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.

Frequently Asked Questions